Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Adderall, ADHD, advent, Amneal, amphetamine, andJune, antibiotic, AscendMethadone, Aspartate, attainment, Aurobindo, Azar, behavior, benchmark, card, catalyst, China, Chinese, Citizen, clarification, cloud, CMS, codeine, codeveloper, codified, combat, Dantrolene, deadline, Dextroamphetamine, disaggregated, disaster, Disorder, distinct, distract, drain, encouraging, Endo, engender, epidemic, excessive, expedient, explain, explanatory, familiarity, feasibility, grantor, hour, housing, Hydroxzine, Hyperactivity, inAccounting, inconsequential, inItem, IQVIA, irrelevance, Lannett, left, lot, Loxapine, loyalty, Mallinckrodt, medium, Mexico, mild, milligram, morphine, Narcolepsy, Nonemployee, Northern, onform, onMarch, overcome, overcoming, PAS, phosphate, pipe, PPACA, PPCA, prompting, prone, QVIA, rationing, reconciling, recordkeeping, Recovery, rescheduled, retaliatory, Rulemaking, Saccharate, salt, seeded, sensitivity, Sodium, Southern, statute, Stewardship, storm, strongly, substitution, Subtopic, Sulfate, sweeping, tariff, TCJA, therapy, toexhibit, Tylenol, unconstitutional, unfilled, unremediated, upfront, USTR, vandalism, variation
Removed:
Acura, adult, agreeing, Allergen, anticipating, antihistamine, await, bankruptcy, Biotime, brompheniramine, CBE, ceased, Celgene, composite, constituting, core, custom, decongestant, delivered, divested, domicile, Durect, economically, encompassing, enhancement, expedited, FDCA, graph, Hong, Impax, Indigo, informed, insolvency, Jerry, Kong, lab, lawfully, liquidating, list, LLCE, MKT, Monograph, NE, peer, placement, principle, pseudoephedrine, reassessed, Reg, reinvestment, relevance, remained, replace, retire, Room, Russell, Street, Subramanian, succeeding, superseded, Supplementary, tangible, Treppel, unaudited, undelivered, undue, unregistered, Unsecured, Valeant, Veerappan, VGS, Willstar
Filing tables
Filing exhibits
- 10-K Annual report
- 10.49 License, Supply and Distribution Agreement Effective April 9, 2019 by and Between Elite Pharmaceuticals, Inc., and Elite Laboratories, Inc. and Lannett Company, Inc., USA
- 10.50 License, Supply and Distribution Agreement Effective March 6, 2019 by and Between Elite Pharmaceuticals, Inc., and Elite Laboratories, Inc. and Lannett Company, Inc., USA
- 10.51 Development Agreement Effective December 3, 2018 by and Between Mikah Pharma LLC and Elite Laboratories, Inc. (Portions of This Agreement Have Been Redacted In Compliance with Regulation S-K Item 601(B)(10))*
- 21 Subsidiary of the Company
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
Associated ELTP transcripts
ELTP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following documents of our reports dated June 14, 2019, relating to the consolidated financial statements of Elite Pharmaceuticals, Inc. and Subsidiary, and the effectiveness of internal control over financial reporting of Elite Pharmaceuticals, Inc. and Subsidiary, included in the Annual Report on Form 10-K of the Company for the year ended March 31, 2019.
Registration Statement No. 333-217866 on Form S-3
Registration Statement No. 333-197694 on Form S-8
Registration Statement No. 333-163907 on Form S-8
Registration Statement No. 333-132140 on Form S-8
Registration Statement No. 333-118524 on Form S-8
/s/ Buchbinder Tunick & Company LLP | |
Wayne, New Jersey | |
June 21, 2019 |